Mark Holdsworth is a partner in the Executive Compensation and Employee Benefits Department. Mark focuses on the executive compensation and employee benefits-related aspects of mergers, acquisitions, public offerings, restructurings, spin-offs and other corporate transactions, including equity compensation and golden parachute arrangements. Mark’s experience includes representation of private equity funds in the negotiation of executive equity, employment, change-in-control, retention and separation agreements, as well as individual executives and management teams in connection with private equity buyouts.
- Axiom management in a strategic investment from Permira funds
- Tornier N.V., a designer, manufacturer and marketer of joint replacement devices, in its $3.3 billion merger with Wright Medical Group, Inc.
- Pamplona Capital Partners in its acquisition of Alvogen Lux Holdings, S.à r.l.*
- Cerberus and its affiliates in the sales of Guilford Mills, Inc. and Titan Television Broadcast Group*
- Veronis Shuler Stevenson in its sale of Ipreo Holdings LLC to Kohlberg Kravis & Roberts & Co, L.P.*
- U.S. Treasury in the sale of certain assets of General Motors Corporation to New GM*
- U.S. Treasury in the sale of a controlling interest in Chrysler’s assets to Fiat S.p.A.*
- Pfizer Inc. in its acquisitions of Wyeth and the sale of its consumer healthcare business to Johnson & Johnson*
- The Bear Stearns Companies Inc. in its acquisition by JP Morgan Chase & Co.*
- Xstrata (Schweiz) A.G. in its sale of Noranda Aluminum to Apollo Management*
* Mark advised on these matters at his prior firm.
Prior to joining Willkie, Mark was a partner at Lowenstein Sandler LLP and special counsel at Cadwalader, Wickersham & Taft LLP.